1. Thailand Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Mahachai Hospital Public Company Limited

Mahachai Hospital Public Company Limited

M-CHAI.BK
Mahachai Hospital Public Company LimitedTH flagStock Exchange of Thailand
18.50
THB
-0.20
- -
2.96BMarket Cap
Mahachai Hospital Public Company Limited
M-CHAI.BK
(Stock Exchange of Thailand)

Recent

price

18.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
8.56
9.22
10.31
10.84
11.36
12.05
13.41
14.24
14.79
15.66
16.05
29.37
37.7
41.44
41.44
40.79
41.03
Revenue per Share
0.52
0.67
0.92
0.98
0.74
1.06
1.09
1.01
0.83
0.72
0.48
2.42
2.41
1.81
0.45
0.95
0.98
Basic EPS, GAAP
0.12
0.93
0.86
0.08
0.2
-0.33
-2.99
-0.2
-4.28
-8.51
-16.6
-4.11
2.65
1.12
2.36
6.6
6.08
Free Cash Flow per Basic Share
0.17
0.21
0.27
0.37
0.39
0.3
0.42
0.44
0.41
0.33
0.3
0.2
0.7
0.8
0.7
0.25
0.25
Dividend per Share
3.06
3.51
4.16
4.77
5.12
5.87
6.55
7.1
7.48
7.85
8
10.23
12
13.01
12.82
13.57
13.72
Book Value per Share
3.69
4.01
4.63
5.27
5.62
6.79
8.74
11.39
15.96
15.97
16.86
18.53
19.82
20.19
19.91
19.81
20.01
Tangible Book Value per Share
160
159
159
159
159
159
159
159
160
160
160
160
160
160
160
160
160
Basic Weighted Avg Shares
1,369
1,464
1,636
1,720
1,802
1,912
2,128
2,264
2,366
2,506
2,568
4,699
6,032
6,630
6,630
6,526
6,565
Sales/Revenue/Turnover
8.47
12.13
12.83
12.21
9.03
10.5
9.52
7.91
8.5
5.68
-1.4
9.52
10.74
10.58
5.73
7.05
7.25
Operating Margin (%)
77
76
79
89
99
118
128
157
169
173
232
646
667
690
750
694
674
Depreciation Expense
83
106
145
155
118
168
173
161
133
115
76
387
385
289
72
153
156
Net Income, GAAP
31.18
33.4
23.9
19.67
21.29
17.01
15.57
14.63
13.62
11.24
- -
16.59
23.37
17.38
19.47
29.58
27.25
Effective Tax Rate (%)
6.03
7.22
8.89
9
6.54
8.77
8.14
7.09
5.63
4.61
2.97
8.23
6.39
4.36
1.08
2.34
2.38
Profit Margin (%)
-104
-186
-138
-111
-116
-227
-313
31
392
-1,180
-1,786
-1,346
-1,550
-1,194
-1,590
-1,206
-1,144
Working Capital
258
127
148
288
357
454
824
951
1,304
1,518
5,638
6,094
5,788
5,823
5,358
5,194
5,087
LT Debt
599
683
785
883
940
1,123
1,428
2,191
2,933
2,941
2,786
3,048
3,244
3,319
3,280
3,260
3,294
Total Equity
8.51
11.98
15.17
13.82
9.16
10.24
7.74
4.73
3.88
2.44
- -
3.7
4.69
5.5
2.91
3.23
3.48
Return on Invested Capital (%)
11.46
13.56
17.06
15.3
10.37
12.16
9.23
5.83
4.19
3.89
- -
9.41
6.47
5.17
3.89
3.83
3.53
Return on Capital (%)
17.89
20.18
23.87
21.86
15.03
19.22
17.57
14.82
11.45
9.41
6.01
26.51
21.67
14.44
3.48
7.24
7.34
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
1,942
1,357
1,320
LT Borrowings
3,500
3,798
3,698
LT Finance Leases
1,377
1,396
1,388
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
160
160
160
Market Capitalization
3,728
2,912
3,040

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
1,276
1,205
1,096
Cash, Cash Equivalents & STI
215
395
228
Accounts Receivable, Net
719
481
445
Inventories
159
177
219
Total Current Liabilities
2,894
2,411
2,240
Payables & Accruals
805
855
796
ST Debt
1,942
1,357
1,320
Deferred Revenue
- -
- -
17

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.59%
3.28%
-0.59%
Free Cash Flow
294.02%
-1.4%
179.37%
Net Income, GAAP
35.1%
83.86%
112.66%
Sales/Revenue/Turnover
- -
- -
-1.56%
Total Cash Common Dividend
16.44%
30.92%
-64.31%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,644
1,612
1,778
1,596
6,630
2025
1,538
1,583
1,724
1,681
6,526
2026
1,577
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.25
-0.02
0.4
- -
0.45
2025
0.12
0.27
0.63
- -
0.95
2026
0.14
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.7
- -
- -
0.7
2025
- -
0.25
- -
- -
0.25
2026
- -
- -
- -
- -
- -
Similar Companies
Auna S.A. (AUNA)
Concord Healthcare Grp Co Ltd (2453.HK)
Aspira Pathlab & Diagnostics Limited (ASPIRA.BO)
PT Sarana Meditama Metropolitan Tbk (SAME.JK)
Wattana Karnpaet Public Company Limited (NEW.BK)
Thonburi Medical Centre Public Company Limited (KDH.BK)
Business
Mahachai Hospital Public Company Limited operates as a private hospital group based in Samut Sakhon, Thailand, founded in 1987. The company provides comprehensive healthcare services including patient treatment, inpatient services, and medical trading. Its medical services encompass a wide range of specialized centers such as Mahachai Heart Center, Gastrointestinal and Liver Center, Hematology and Oncology Clinic, Orthopedic Clinic, Eye Clinic, Surgical Clinic, Pulmonary and Respiratory Clinic, Dental and Implant Center, Neurology Clinic, Diabetes Care Center, Internal Medicine Clinic, Sleep Disorders Center, Physical Medicine and Rehabilitation Center, Pediatric Clinic, Ear, Nose and Throat Clinic, Obstetrics and Gynecology Clinic, Urology Clinic, Health Check-up Center, and Kidney and Hemodialysis Center. Mahachai Hospital operates multiple facilities under the brand names Mahachai, Mahachai 2, Mahachai Petcharat, Mahachai 3, Mahachai Maeklong, Mahachai Prompathya, and Med Park Hospital. The company primarily serves the Thai healthcare market with a focus on private hospital services and the trading of medical supplies. In recent years, Mahachai Hospital has expanded its hospital network and service capabilities to meet growing healthcare demands. Notably, in 2025, the company reported steady revenue growth with a hospital and medical trading business revenue reaching approximately 6.73 billion THB. Recent strategic actions include acquisitions and increased stakes in affiliated healthcare entities to broaden its operational footprint and service range. The company also continues to invest in specialized medical centers and advanced healthcare technologies to enhance patient care quality. Mahachai Hospital Public Company Limited remains committed to expanding its healthcare services across Thailand with an employee base of over 1,700 personnel, reflecting its position as a significant private healthcare provider in the region. The company maintains its headquarters in Samut Sakhon and demonstrates consistent operational growth driven by both organic expansion and strategic partnerships. It emphasizes a comprehensive healthcare offering spanning general and specialized medical treatment, supported by a widespread hospital network and medical supply trading operations.